3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
32
Carcinoma, Intraductal, Noninfiltrating
5
Breast Carcinoma In Situ
4
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Infertility
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasms by Site
1
Hypogonadism
1
Hot Flashes
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ductal
1
Anovulation
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
testosterone undecanoate
1
testosterone 17 beta-cypionate
1
Testosterone Propionate
1
Testosterone
1
Tamoxifen
1
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Methyltestosterone
1
Mental Status and Dementia Tests
1
Gels
1
Drug Evaluation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypogonadism
×
Tamoxifen
×
90 days
×
Clear all
NCT07535905
2026-04-17
REVIVE
University Health Network, Toronto
Phase 2
Not yet recruiting
96 enrolled